The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) COO Daniel Mcbride acquired 3,000 shares of the firm's stock in a transaction that occurred on Tuesday, September 2nd. The stock was purchased at an average price of $65.04 per share, with a total value of $195,120.00. Following the completion of the acquisition, the chief operating officer owned 63,120 shares in the company, valued at $4,105,324.80. The trade was a 4.99% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.
Cooper Companies Stock Down 3.1%
NASDAQ COO traded down $2.06 during mid-day trading on Tuesday, reaching $65.33. The stock had a trading volume of 3,767,636 shares, compared to its average volume of 2,276,406. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $112.38. The stock has a market cap of $12.99 billion, a PE ratio of 32.18, a price-to-earnings-growth ratio of 1.63 and a beta of 0.97. The company has a fifty day moving average price of $72.25 and a 200 day moving average price of $77.14. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24.
Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts' consensus estimates of $1.07 by $0.03. The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on the stock. Morgan Stanley set a $76.00 target price on shares of Cooper Companies and gave the company an "equal weight" rating in a research note on Thursday, August 28th. Mizuho decreased their target price on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. Piper Sandler decreased their target price on shares of Cooper Companies from $105.00 to $83.00 and set an "overweight" rating for the company in a research note on Thursday, August 28th. Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Finally, BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective for the company in a research report on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $86.64.
View Our Latest Stock Analysis on COO
Institutional Investors Weigh In On Cooper Companies
A number of hedge funds have recently modified their holdings of COO. Sustainable Growth Advisers LP bought a new stake in shares of Cooper Companies during the 2nd quarter valued at $240,881,000. Ameriprise Financial Inc. boosted its holdings in Cooper Companies by 98.8% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company's stock worth $241,120,000 after buying an additional 1,683,561 shares during the period. Franklin Resources Inc. boosted its holdings in Cooper Companies by 7,723.3% in the 2nd quarter. Franklin Resources Inc. now owns 1,569,512 shares of the medical device company's stock worth $111,686,000 after buying an additional 1,549,450 shares during the period. Findlay Park Partners LLP boosted its holdings in Cooper Companies by 312.5% in the 2nd quarter. Findlay Park Partners LLP now owns 1,815,900 shares of the medical device company's stock worth $129,219,000 after buying an additional 1,375,657 shares during the period. Finally, Soundwatch Capital LLC bought a new position in Cooper Companies in the 2nd quarter worth $607,000. Institutional investors own 24.39% of the company's stock.
About Cooper Companies
(
Get Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.